Matches in SemOpenAlex for { <https://semopenalex.org/work/W67565765> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- W67565765 endingPage "161" @default.
- W67565765 startingPage "157" @default.
- W67565765 abstract "It is now well established that cyclooxygenase exists in two major isoforms, namely cyclooxygnease-1 (Cox-1) and cyclooxygenase-2 (Cox-2). The constitutive isoform, Cox-1, has been well characterized, and the sheep, mouse and human forms have been cloned (DeWitt and Smith, 1988; DeWitt et al., 1990; Yokoyama and Tanabe, 1989). It has been proposed that Cox-1 is involved in the maintenance of prostaglandin-mediated physiological functions, in particular cytoprotection in the stomach. In contrast, Cox-2, which has been extensively studied recently (O’Neill et al., 1994; Percival et al., 1994; Smith and Marnett, 1994; Herschman, 1994), is present in negligible amounts in normal stomach tissues (Kargman et al., data to be published). Cox-2 has been shown to be induced substantially in vivo under inflammatory conditions (Kennedy et al., 1993; Masferrer et al., 1994; Harrada et al., 1994). This has led to the hypothesis that Cox-1 and Cox-2 serve different physiological and pathological functions. Currently available non-steroidal anti-inflammatory drugs (NSAIDs) are non-selective cyclooxygenase inhibitors, which inhibit both Cox-1 and Cox-2 (Mead et al., 1993; Mitchell et al, 1994; Brideau et al, 1995). It is believed that gastrointestinal ulcerogenic effects commonly associated with these NSAIDs may be related to mechanism-based toxicity, i. e. via an inhibitory action on Cox-1 in the gastrointestinal tissues. On the other hand, if the anti-inflammatory activity of NSAIDs is predominantly due to the inhibition of Cox-2, selective inhibitors of Cox-2 may comprise a new class of therapeutic agents which possess similar anti-inflammatory effects to conventional NSAIDs, but with a substantially improved side effect profile. In this article, the pharmacology of a selective Cox-2 inhibitor, L-745,337 (5-methanesulfonamido-6-(2,4-difluorothiophenyl)-1 -indanone) in various in vitro and in vivo animal models is reviewed." @default.
- W67565765 created "2016-06-24" @default.
- W67565765 creator A5075106875 @default.
- W67565765 creator A5081961820 @default.
- W67565765 date "1997-01-01" @default.
- W67565765 modified "2023-10-18" @default.
- W67565765 title "Selective Cyclooxygenase-2 Inhibitors as Potential Therapeutic Agents for Inflammatory Diseases" @default.
- W67565765 cites W1490609633 @default.
- W67565765 cites W1536681507 @default.
- W67565765 cites W1968162098 @default.
- W67565765 cites W1982273085 @default.
- W67565765 cites W1997364548 @default.
- W67565765 cites W2002341330 @default.
- W67565765 cites W2014644245 @default.
- W67565765 cites W2014664456 @default.
- W67565765 cites W2026732117 @default.
- W67565765 cites W2063144963 @default.
- W67565765 cites W2066074947 @default.
- W67565765 cites W2083748640 @default.
- W67565765 cites W2100417337 @default.
- W67565765 doi "https://doi.org/10.1007/978-1-4899-1813-0_24" @default.
- W67565765 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9321947" @default.
- W67565765 hasPublicationYear "1997" @default.
- W67565765 type Work @default.
- W67565765 sameAs 67565765 @default.
- W67565765 citedByCount "9" @default.
- W67565765 countsByYear W675657652013 @default.
- W67565765 countsByYear W675657652016 @default.
- W67565765 countsByYear W675657652017 @default.
- W67565765 countsByYear W675657652018 @default.
- W67565765 crossrefType "book-chapter" @default.
- W67565765 hasAuthorship W67565765A5075106875 @default.
- W67565765 hasAuthorship W67565765A5081961820 @default.
- W67565765 hasConcept C181199279 @default.
- W67565765 hasConcept C185592680 @default.
- W67565765 hasConcept C2779689624 @default.
- W67565765 hasConcept C55493867 @default.
- W67565765 hasConcept C71924100 @default.
- W67565765 hasConcept C98274493 @default.
- W67565765 hasConceptScore W67565765C181199279 @default.
- W67565765 hasConceptScore W67565765C185592680 @default.
- W67565765 hasConceptScore W67565765C2779689624 @default.
- W67565765 hasConceptScore W67565765C55493867 @default.
- W67565765 hasConceptScore W67565765C71924100 @default.
- W67565765 hasConceptScore W67565765C98274493 @default.
- W67565765 hasLocation W675657651 @default.
- W67565765 hasLocation W675657652 @default.
- W67565765 hasOpenAccess W67565765 @default.
- W67565765 hasPrimaryLocation W675657651 @default.
- W67565765 hasRelatedWork W1990756964 @default.
- W67565765 hasRelatedWork W2032043921 @default.
- W67565765 hasRelatedWork W2049255613 @default.
- W67565765 hasRelatedWork W2053833211 @default.
- W67565765 hasRelatedWork W2078752732 @default.
- W67565765 hasRelatedWork W2084306326 @default.
- W67565765 hasRelatedWork W2374393856 @default.
- W67565765 hasRelatedWork W2748952813 @default.
- W67565765 hasRelatedWork W2899084033 @default.
- W67565765 hasRelatedWork W3141189303 @default.
- W67565765 isParatext "false" @default.
- W67565765 isRetracted "false" @default.
- W67565765 magId "67565765" @default.
- W67565765 workType "book-chapter" @default.